Literature DB >> 23038792

Surgical outcomes of severe tricuspid regurgitation: predictors of adverse clinical outcomes.

Joon Bum Kim1, Sung-Ho Jung, Suk Jung Choo, Cheol Hyun Chung, Jae Won Lee.   

Abstract

BACKGROUND: Although recent studies contributed to an improved understanding of the prognosis of patients undergoing tricuspid valve (TV) surgery, the data are limited to certain causes of tricuspid regurgitation (TR) or types of surgery.
OBJECTIVE: This study aimed to identify predictors of clinical outcomes of patients undergoing TV surgery for severe TR of various aetiologies.
DESIGN: A retrospective cohort study.
SETTING: A single tertiary referral centre. PATIENTS: 449 consecutive patients (152 men, aged 56.2±12. 3 years) who underwent TV surgery (397 repairs and 52 replacements) due to severe TR between 1997 and 2010. MAIN OUTCOME MEASURES: The primary outcome of interest was death from any cause.
RESULTS: The early death rate was 4.2% (n=19) and 101 patients died in the late period (median follow-up of 63.3 months; range 0-210.4 months). The 5- and 10-year survival rates were 82.4±1.9% and 71.7±2.8%, respectively. Cox-regression analysis revealed that age (HR=1.03; 95% CI 1.01 to 1.05), male gender (HR=1.96; 95% CI 1.29 to 2.99), New York Heart Association functional class IV (HR=2.08; 95% CI 1.31 to 3.30), presence of liver cirrhosis (HR=2.51; 95% CI 1.11 to 5.68) and preoperative levels of haemoglobin (HR=0.89; 95% CI 0.80 to 0.99), albumin (HR=0.52; 95% CI 0.33 to 0.81) and estimated glomerular filtration rate (HR=0.86; 95% CI 0.78 to 0.95) were independent determinants of mortality. Procedural type (p=0.58) or causes of TR (p=0.97), however, were not predictive of mortality.
CONCLUSIONS: Long-term survival after TV surgery for severe TR was affected by several preoperative factors including advanced heart failure symptom, comorbidity, end-organ dysfunction and laboratory abnormalities, but not by the type of surgery or causes of TR.

Entities:  

Mesh:

Year:  2012        PMID: 23038792     DOI: 10.1136/heartjnl-2012-302856

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  7 in total

1.  The impact of tricuspid annular geometry on outcome after percutaneous edge-to-edge repair for severe tricuspid regurgitation.

Authors:  Sylvia Otto; Marija Velichkov; Ali Hamadanchi; P Christian Schulze; Sven Moebius-Winkler
Journal:  Cardiol J       Date:  2021-05-04       Impact factor: 2.737

Review 2.  [Tricuspid valve regurgitation : Indications and operative techniques].

Authors:  R Lange; N Piazza; T Günther
Journal:  Herz       Date:  2017-11       Impact factor: 1.443

Review 3.  Contemporary review in the multi-modality imaging evaluation and management of tricuspid regurgitation.

Authors:  Tom Kai Ming Wang; Shinya Unai; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

4.  Surgery Does Not Improve Survival in Patients With Isolated Severe Tricuspid Regurgitation.

Authors:  Andrea L Axtell; Vijeta Bhambhani; Philicia Moonsamy; Emma W Healy; Michael H Picard; Thoralf M Sundt; Jason H Wasfy
Journal:  J Am Coll Cardiol       Date:  2019-05-06       Impact factor: 24.094

5.  Tricuspid regurgitation: clinical importance and its optimal surgical timing.

Authors:  Hyung-Kwan Kim; Seung-Pyo Lee; Yong-Jin Kim; Dae-Won Sohn
Journal:  J Cardiovasc Ultrasound       Date:  2013-03-20

Review 6.  Secondary tricuspid valve regurgitation: a forgotten entity.

Authors:  Pilar Tornos Mas; José F Rodríguez-Palomares; Manuel J Antunes
Journal:  Heart       Date:  2015-11       Impact factor: 5.994

7.  Comparative early outcomes of tricuspid Valve repair versus replacement for secondary tricuspid regurgitation.

Authors:  Mohamad Alkhouli; Chalak Berzingi; Amer Kowatli; Fahad Alqahtani; Vinay Badhwar
Journal:  Open Heart       Date:  2018-09-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.